Skip to main content
. 2019 May 17;13:485. doi: 10.3389/fnins.2019.00485

Figure 2.

Figure 2

Kaplan-Meier plots of survival probabilities: the patients carrying the pathogenic C9orf72 repeat expansion (or ALS-C9Pos, red line) display shorter survival time [median survival of 36 months (95% CI 30–43)] than the patients without genetic mutations (ALSwoGM, green line) [median survival of 42 months (95% CI 39–45)]. Log-rank χ2 = 3.88, p = .049; +: censored cases.